MP-20.01: Gut Microbiota-Derived Aminoadipic Acid Promotes Castration Resistance of Prostate Cancer via Activating Akt-Foxo1-Pck2 Mediated Gluconeogenesis
Presenting Author: Yufei Liu – Huashan Hospital, Fudan University
Prostate Cancer - Clinical Advanced
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-20.02: Huangqi Derived Exosome Like Nanoparticles Exert Therapeutic Effects on Prostate Cancer by Inducing Ferroptosis and Modulating the Polarization of Macrophages
Presenting Author: Qidong Xia – Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Prostate Cancer - Clinical Advanced
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-20.03: Impact of Progression-Directed Therapy in Patients with Oligoprogressive Castration-Resistant Prostate Cancer on Overall Survival and Progression-Free Survival
Presenting Author: Sang Hee Lee – Kyungpook National University Hospital
Prostate Cancer - Clinical Advanced
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-20.04: Predictive Model Combining Clinical and MRI Data for Detecting Clinically Significant Prostate Cancer Using Elastic Fusion Registration
Presenting Author: Trung Thanh TRAN – (1) University Cancer Institute of Toulouse - Oncopole, France
(2) LaTIM - INSERM UMR1101, University of Western Brittany, France
(3) Hanoi Medical University Hospital, Vietnam
Prostate Cancer - Clinical Advanced
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-20.05: Response Evaluation Criteria for Neoadjuvant Hormonal Therapy in Prostate Cancer Based on Magnetic Resonance Imaging: a Multicenter Retrospective Study
RF-20.01: Whole Genome Sequencing as an Integrated Framework for Diagnosis, Therapy, and Prognostic Stratification: Advancing Precision Medicine in Indonesia
